A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Clinical trial NCT03092895 · COMPLETED

Trial details

NCT number: NCT03092895
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Primary Liver Cancer Advanced Biliary Tract Carcinoma

Start date: 2017-04-24
Primary completion: 2021-03-31
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.